Sat, Sep 28, 2024
The US Food and Drug Administration (USFDA) inspected the company's Pithampur Unit-1 API and finished product manufacturing facility from September 16 to September 27, 2024.
More >
Wed, Sep 18, 2024
Under the terms of this agreement, Takeda has granted Lupin non-exclusive patent licensing rights to commercialise Vonoprazan in India.
Fri, Sep 13, 2024
Sunsure Energy and Lupin Ltd announced the signing of a 21 MW (31.5 MWp) solar Open Access Power Purchase Agreement (PPA).
Wed, Jan 11, 2023
Jefferies and HSBC have recommended, Cipla, Sun Pharma, Divi's Laboratories, Biocon, Lupin and others
Fri, Dec 23, 2022
Why Astha Jain suggests to buy Lupin on Technical Charts? Watch this video for more details.
Tue, Nov 29, 2022
Technical expert Simi Bhaumik expects an upside of Rs 25-30 which will open if the stock decisively breaches levels of Rs 759, its November high.
In today's edition of Traders Diary, Zee Business research team brings its exclusive research on 20 stocks that investors and traders can refer to while making their strategies in them
Tue, Nov 15, 2022
Thu, Nov 10, 2022
Shares of Lupin rallied 3% on Nov 10 after the company announced a consolidated net profit of Rs 130 crore for September quarter 2022-23
Lupin Share Price: The drug maker on Wednesday said its consolidated net profit stood at Rs 130 crore for the second quarter ended September 30, 2022.
Fri, Oct 07, 2022
"Through this, we will further reinforce our long legacy to provide shorter, more patient-friendly treatment options to prevent TB," Lupin Managing Director Nilesh Gupta said in a statement.
Tue, Oct 04, 2022
Lupin will also potentially have shared 180-day exclusivity on the 600 mg tablets.
Fri, Sep 30, 2022
Lupin share price on Friday jumped over 4 per cent as it received the US FDA nod for manufacturing a new drug to treat overactive bladder at the company's facility in Nagpur.
Thu, Sep 29, 2022
Received warning letter for Tarapur plant from US FDA. The plant was investigated from March 22 to April 4. Will address US FDA concerns soon: Lupin.
Thu, Aug 04, 2022
What should be the caution today in lupin? Which companies produced poor results? Why focus on fertilizer chemical companies? Know the analysis of June quarter results from Anil Singhvi.
Wed, Mar 02, 2022
Certain stocks were in action in either direction based on reports linked to them. Here is a list of some of such stocks.
Tue, Feb 08, 2022
Indian market snapped a three-day losing streak and closed in positive on Tuesday.
Mon, Feb 07, 2022
Rakesh Jhunjhunwala–backed Lupin shares touched a new 52-week low to Rs 806.05 per share, slipping by 7.5 per cent on the BSE on the intraday basis on Monday.
Fri, Feb 04, 2022
In Q3FY22, the drugmaker’s EBITDA (earnings before interest tax and depreciation and amortization) margins dipped by 580 basis points (bps) sequentially, 1,050 bps year-on-year (YoY) to 9.9 per cent.
In line with the announcements of quarterly earnings results in this season Drugmaker Lupin on Friday reported a 24.45 per cent rise in its consolidated net profit at Rs 545.5 crore for the third quarter ended December 31. Here are key highlights of the result
Fri, Dec 24, 2021
Homegrown pharmaceuticals major Lupin on Friday said it has received tentative approval from the US health regulator for its generic Azilsartan Medoxomil tablets used to treat high blood pressure.
Fri, Dec 10, 2021
Homegrown pharma major Lupin Ltd on Friday announced the launch of its diagnostics arm as part of its strategy to provide integrated healthcare in India.
Thu, Dec 02, 2021
Pharma major Lupin Ltd on Thursday said its wholly-owned arm Lupin Inc has inked a pact with TTP Plc to acquire exclusive worldwide rights to develop, manufacture and commercialise inhalation products, using the latter's soft-mist inhalation technology platform.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
